Immunocore Historical Cash Flow
| IMCR Stock | USD 29.00 0.80 2.68% |
Analysis of Immunocore Holdings cash flow over time is an excellent tool to project Immunocore Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 27.4 M or Change To Operating Activities of 545.3 K as it is a great indicator of Immunocore Holdings ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Immunocore Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immunocore Holdings is a good buy for the upcoming year.
Immunocore |
About Immunocore Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Immunocore balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Immunocore's non-liquid assets can be easily converted into cash.
Immunocore Holdings Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Immunocore Holdings' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Immunocore Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.At this time, Immunocore Holdings' Change In Working Capital is relatively stable compared to the past year. As of 03/11/2025, Change To Inventory is likely to grow to about 35.1 M, while Total Cashflows From Investing Activities is likely to drop slightly above 165 K.
Immunocore Holdings cash flow statement Correlations
Click cells to compare fundamentals
Immunocore Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunocore Holdings cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Cashflows From Investing Activities | (4.1M) | 467K | (367K) | 193K | 173.7K | 165.0K | |
| Other Cashflows From Financing Activities | (145.2K) | (10.6M) | (1.3M) | 34.3M | (8.6M) | (8.2M) | |
| Capital Expenditures | 3.1M | 1.0M | 2.2M | 5.4M | 5.2M | 3.7M | |
| Total Cash From Operating Activities | (60.6M) | (129.7M) | (31.3M) | 2.9M | 26.1M | 27.4M | |
| Change To Operating Activities | (21.9M) | (24.5M) | (21.3M) | 577K | 519.3K | 545.3K | |
| Other Cashflows From Investing Activities | 3.5M | 513K | 2.4M | (1.2M) | 44K | 41.8K | |
| Change To Netincome | 3.4M | 33.3M | 45.4M | 22.1M | 25.4M | 26.7M | |
| Change To Liabilities | 9.9M | (3.8M) | 9.5M | 18.6M | 21.4M | 22.5M | |
| Investments | 467K | (367K) | 193K | 4.8M | (355.1M) | (337.4M) | |
| Change In Cash | 55.8M | 146.0M | 114.3M | 40.2M | 13.1M | 12.4M | |
| Depreciation | 9.0M | 7.0M | 6.1M | 4.1M | 4.2M | 5.0M | |
| Change To Account Receivables | (532K) | (5.1M) | (32.1M) | (17.9M) | (12.3M) | (13.0M) | |
| Net Income | (74.1M) | (131.5M) | (41.2M) | (43.4M) | (51.1M) | (53.6M) | |
| Total Cash From Financing Activities | 115.9M | 276.3M | 138.2M | 34.3M | 343.9M | 361.1M | |
| End Period Cash Flow | 129.7M | 321.1M | 401.6M | 442.6M | 455.7M | 279.4M | |
| Stock Based Compensation | 8.2M | 48.9M | 32.9M | 32.5M | 34.2M | 25.2M | |
| Free Cash Flow | (63.6M) | (130.8M) | (33.5M) | (2.5M) | 20.9M | 21.9M | |
| Change In Working Capital | (28.8M) | (16.8M) | (12.9M) | 5.8M | 45.1M | 47.4M | |
| Begin Period Cash Flow | 74.0M | 175.1M | 287.3M | 402.5M | 442.6M | 249.7M | |
| Other Non Cash Items | 38.5M | (14.9M) | (7.4M) | 4.0M | (6.4M) | (6.1M) |
Pair Trading with Immunocore Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immunocore Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Immunocore Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immunocore Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immunocore Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immunocore Holdings to buy it.
The correlation of Immunocore Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunocore Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunocore Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immunocore Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.